$599

MannKind Partners with GoodRx

MannKind announced it formed a partnership with GoodRx to “help raise awareness on ways patients can save money on their mealtime insulin.” Recall, GoodRx is a platform designed for patients without insurance or high-deductible plans to help them compare drug prices and identify savings opportunities (e.g. copay cards). Of note, the MannKind press release appears to suggest that the sole purpose of the partnership is to promote the Afrezza copay card. Below, FENIX provides brief thoughts on the MannKind partnership with GoodRx.

About The Author

Matthew Maryniak

|
President of Fenix Group International

Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.

If you receive our email blasts, you already have an account.

Purchase Blast$599.00

You can read the article’s full content online after purchase.